Formation of lysine 63-linked poly-ubiquitin chains protects human lung cells against benzo[a]pyrene-diol-epoxide-induced mutagenicity

DNA Repair

Volumn 6, Issue 6, 2007, Pages 852-862

  Langie, Sabine A S ^a   Knaapen, Ad M ^a   Ramaekers, Chantal H M A ^a   Theys, Jan ^a   Brun, Jan ^b   Godschalk, Roger W L ^a   van Schooten, Frederik J ^a   Lambin, Philippe ^a   Gray, Douglas A ^b   Wouters, Bradly G ^a   Chiu, Roland K ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Benzo(a)pyrene; DNA damage tolerance; Mutagenesis; Translesion synthesis; Ubiquitin

Indexed keywords

CYCLINE; DIHYDROXYBENZO[A]PYRENE OXIDE; LYSINE DERIVATIVE; POLYUBIQUITIN; SMALL INTERFERING RNA;

ARTICLE; CARCINOGENESIS; CELL PROTECTION; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MUTAGENESIS; MUTAGENICITY; POINT MUTATION; PRIORITY JOURNAL; UBIQUITINATION;

BENZO(A)PYRENE; CELL LINE, TUMOR; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUNG; LUNG NEOPLASMS; LYSINE; MUTAGENS; POLYUBIQUITIN; ULTRAVIOLET RAYS;

EID: 34247616789     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2007.02.012     Document Type: Article

References (41)

1. Phillips D.H. Fifty years of benzo(a)pyrene. Nature 303 (1983) 468-472
2. Peltonen K., and Dipple A. Polycyclic aromatic hydrocarbons: chemistry of DNA adduct formation. J. Occup. Environ. Med. 37 (1995) 52-58
3. Cheng S.C., Hilton B.D., Roman J.M., and Dipple A. DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide. Chem. Res. Toxicol. 2 (1989) 334-340
4. Moriya M., Spiegel S., Fernandes A., Amin S., Liu T., Geacintov N., and Grollman A.P. Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2′-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. Biochemistry 35 (1996) 16646-16651
5. Broomfield S., Hryciw T., and Xiao W. DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae. Mutat. Res. 486 (2001) 167-184
6. Wang Z. DNA damage-induced mutagenesis: a novel target for cancer prevention. Mol. Interv. 1 (2001) 269-281
7. Friedberg E.C., Lehmann A.R., and Fuchs R.P. Trading places: how do DNA polymerases switch during translesion DNA synthesis?. Mol. Cell. 18 (2005) 499-505
8. Ogi T., Shinkai Y., Tanaka K., and Ohmori H. Polkappa protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15548-15553
9. 2-dG adducts by human DNA polymerases eta and kappa. Mutat. Res. 510 (2002) 23-35
10. Lehmann A.R. Replication of damaged DNA by translesion synthesis in human cells. FEBS Lett. 579 (2005) 873-876
11. Rechkoblit O., Zhang Y., Guo D., Wang Z., Amin S., Krzeminsky J., Louneva N., and Geacintov N.E. Trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases. J. Biol. Chem. 277 (2002) 30488-30494
12. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., and Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419 (2002) 135-141
13. Hofmann R.M., and Pickart C.M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 96 (1999) 645-653
14. Spence J., Sadis S., Haas A.L., and Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell Biol. 15 (1995) 1265-1273
15. Stelter P., and Ulrich H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425 (2003) 188-191
16. Leach C.A., and Michael W.M. Ubiquitin/SUMO modification of PCNA promotes replication fork progression in Xenopus laevis egg extracts. J. Cell Biol. 171 (2005) 947-954
17. Kannouche P.L., Wing J., and Lehmann A.R. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14 (2004) 491-500
18. Chiu R.K., Brun J., Ramaekers C., Theys J., Weng L., Lambin P., Gray D.A., and Wouters B.G. Lysine 63-polyubiquitination guards against translesion synthesis-induced mutations. PLoS Genet. 2 (2006) e116
19. Tsirigotis M., Zhang M., Chiu R.K., Wouters B.G., and Gray D.A. Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents. J. Biol. Chem. 276 (2001) 46073-46078
20. van Schooten F.J., Hillebrand M.J., Scherer E., den Engelse L., and Kriek E. Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach. Carcinogenesis 12 (1991) 427-433
21. Godschalk R.W., Maas L.M., Van Zandwijk N., van't Veer L.J., Breedijk A., Borm P.J., Verhaert J., Kleinjans J.C., and van Schooten F.J. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis 19 (1998) 819-825
22. Li Z., Zhang H., McManus T.P., McCormick J.J., Lawrence C.W., and Maher V.M. hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts. Mutat. Res. 510 (2002) 71-80
23. Andersson B., Falt S., and Lambert B. Strand specificity for mutations induced by (+)-anti BPDE in the hprt gene in human T-lymphocytes. Mutat. Res. 269 (1992) 129-140
24. McGregor W.G., Wei D., Chen R.H., Maher V.M., and McCormick J.J. Relationship between adduct formation, rates of excision repair and the cytotoxic and mutagenic effects of structurally-related polycyclic aromatic carcinogens. Mutat. Res. 376 (1997) 143-152
25. Bi X., Barkley L.R., Slater D.M., Tateishi S., Yamaizumi M., Ohmori H., and Vaziri C. Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest. Mol. Cell Biol. 26 (2006) 3527-3540
26. Kannouche P., Broughton B.C., Volker M., Hanaoka F., Mullenders L.H., and Lehmann A.R. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev. 15 (2001) 158-172
27. Ogi T., Kannouche P., and Lehmann A.R. Localisation of human Y-family DNA polymerase kappa: relationship to PCNA foci. J. Cell Sci. 118 (2005) 129-136
28. Bi X., Slater D.M., Ohmori H., and Vaziri C. DNA polymerase kappa is specifically required for recovery from the benzo[a]pyrene-dihydrodiol epoxide (BPDE)-induced S-phase checkpoint. J. Biol. Chem. 280 (2005) 22343-22355
29. Li Z., Xiao W., McCormick J.J., and Maher V.M. Identification of a protein essential for a major pathway used by human cells to avoid UV-induced DNA damage. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 4459-4464
30. Watanabe K., Tateishi S., Kawasuji M., Tsurimoto T., Inoue H., and Yamaizumi M. Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 23 (2004) 3886-3896
31. Hess M.T., Gunz D., Luneva N., Geacintov N.E., and Naegeli H. Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Mol. Cell Biol. 17 (1997) 7069-7076
32. Luch A. Nature and nurture-lessons from chemical carcinogenesis. Nat. Rev. Cancer 5 (2005) 113-125
33. Denissenko M.F., Pao A., Pfeifer G.P., and Tang M. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene 16 (1998) 1241-1247
34. Hanawalt P.C., Donahue B.A., and Sweder K.S. Repair and transcription. Collision or collusion?. Curr. Biol. 4 (1994) 518-521
35. Mitchell J.R., Hoeijmakers J.H., and Niedernhofer L.J. Divide and conquer: nucleotide excision repair battles cancer and ageing. Curr. Opin. Cell Biol. 15 (2003) 232-240
36. Le Calvez F., Mukeria A., Hunt J.D., Kelm O., Hung R.J., Taniere P., Brennan P., Boffetta P., Zaridze D.G., and Hainaut P. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 65 (2005) 5076-5083
37. Denissenko M.F., Pao A., Tang M., and Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274 (1996) 430-432
38. Sasaki H., Moriyama S., Nakashima Y., Yukiue H., Fukai I., and Fujii Y. Decreased Hrad6B expression in lung cancer. Acta Oncol. 43 (2004) 585-589
39. Jahngen-Hodge J., Obin M.S., Gong X., Shang F., Nowell Jr. T.R., Gong J., Abasi H., Blumberg J., and Taylor A. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 272 (1997) 28218-28226
40. Obin M., Shang F., Gong X., Handelman G., Blumberg J., and Taylor A. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J. 12 (1998) 561-569
41. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272 (1997) 20313-20316